https://dxm-atlas.org/en/interactions/pethidine/
CompareKey points for this combination
In cell tests with human transporters, pethidine (meperidine) inhibited serotonin reuptake [5]. The oral meperidine label describes respiratory depression and seizures associated with metabolite accumulation during prolonged use [52].
General concepts in this text
Reuptake
Return of a released neurotransmitter into a cell through a transporter protein.
Allows neurotransmitter recycling.
Sources: Reuptake
- OpenStax: General Neurochemistry Principles · Introduction to Behavioral Neuroscience, published 2024-11-13
Metabolite
A substance formed when another substance is chemically transformed in the body.
Some transformation products retain pharmacological activity.
Sources: Metabolite
- IUPHAR Pharmacology Education Project: Clinical pharmacokinetics · Live page accessed 2026-10-12; revision label unavailable
Serotonin
A neurotransmitter: a substance that carries a chemical signal from a nerve cell.
There are different serotonin receptors in the brain and other parts of the body. The response to the signal depends on the receptor and its location.
Sources: Serotonin
- OpenStax: Neural Communication · Introduction to Behavioral Neuroscience, published 2024-11-13
- OpenStax: Neurotransmitters Made from Amino Acids — Serotonin · Introduction to Behavioral Neuroscience, published 2024-11-13
Drug metabolism
Chemical transformation of a medicine in the body.
The resulting substances are metabolites. Transformation can reduce or increase pharmacological activity.
Sources: Drug metabolism
- IUPHAR Pharmacology Education Project: Drug metabolism · Live page accessed 2026-10-12; revision label unavailable
How well is this understood?
Mechanism confidence: high
Confidence in the mechanism: high
M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.
MethodConfidence in human DXM data: low
Confidence in direct human evidence involving DXM: low
M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.
MethodHow do the substances interact?
How can the effects add up?
ⓘ
μ-opioid effects and associated respiratory hazards
ⓘ
SERT
A transporter protein involved in serotonin reuptake.
Inhibiting transport differs from acting on receptors.
Sources: SERT
- IUPHAR Pharmacology Education Project: Receptors · Live page accessed 2026-10-12; revision label unavailable
What hazards does the other substance have?
Product prescribing information; warnings about the opioid’s own effects.
- The oral meperidine label warns of respiratory depression.
- The oral meperidine label associates prolonged use and metabolite accumulation with toxicity including seizures.
Label findings below:
What remains unknown?
The scope is the opioid’s own pharmacology as described in its prescribing information.
Sources
Check the review’s wording
- [5] Opioid-induced inhibition of the human 5-HT and noradrenaline transporters in vitro: link to clinical reports of serotonin syndrome · Open publication
- [52] DEMEROL oral prescribing information · Open publication : Full prescribing information · Open publication : 5.4 Respiratory depression · Open publication : 5.15 Seizures and metabolite accumulation
Evidence and sources
Prescribing information
[52] · DEMEROL oral prescribing information
Respiratory depression
- What does the label say?
The oral meperidine label warns of respiratory depression.
- Source type
Product prescribing information; warnings about the opioid’s own effects.
Metabolite accumulation and seizures
- What does the label say?
The oral meperidine label associates prolonged use and metabolite accumulation with toxicity including seizures.
- What does this label information cover?
The scope is the opioid’s own pharmacology as described in its prescribing information.